Joseph P. Balint
Corporate Officer/Principal chez Etubics Corp.
Profil
Joseph P.
Balint is currently the Laboratory Director at Etubics Corp.
Previously, he worked at Cypress Bioscience, Inc. from 1982 to 1996, where he held the position of Director-Extracorporeal Products in 1989.
He obtained a doctorate degree from Rutgers State University of New Jersey.
Postes actifs de Joseph P. Balint
| Sociétés | Poste | Début |
|---|---|---|
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Anciens postes connus de Joseph P. Balint
| Sociétés | Poste | Fin |
|---|---|---|
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | 01/01/1989 |
Formation de Joseph P. Balint
| Rutgers State University of New Jersey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Health Technology |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
